BioNxt issues 16,900,000 share purchase warrants at exercise price of $0.5 per share

Reuters2026/08/21 22:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BioNxt issued 16,900,000 common share purchase warrants tied to an extension of unsecured convertible debentures.
Each warrant allows purchase of one common share at an exercise price of $0.5 through Aug. 21, 2027.
Debenture maturities were pushed out by one year, with interest unchanged at 8%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNxt Solutions Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608211830ACCESSWRNAPR_____1210611) on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

BioNxt issues 16,900,000 share purchase warrants at exercise price of $0.5 per share

You may also like

Crypto prices